1. Home
  2. STTK vs FRBA Comparison

STTK vs FRBA Comparison

Compare STTK & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$4.56

Market Cap

474.6M

Sector

Health Care

ML Signal

N/A

Logo First Bank

FRBA

First Bank

N/A

Current Price

$18.98

Market Cap

508.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
FRBA
Founded
2016
2007
Country
United States
United States
Employees
N/A
336
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
474.6M
508.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
FRBA
Price
$4.56
$18.98
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$15.40
★ $21.67
AVG Volume (30 Days)
★ 841.6K
105.7K
Earning Date
11-05-2026
10-22-2026
Dividend Yield
N/A
★ 2.49%
EPS Growth
★ 53.02
N/A
EPS
N/A
★ N/A
Revenue
★ $1,000,000.00
N/A
Revenue This Year
N/A
$2.61
Revenue Next Year
$14.28
$5.91
P/E Ratio
★ N/A
$9.71
Revenue Growth
N/A
★ N/A
52 Week Low
$1.89
$14.41
52 Week High
$8.33
$21.29

Technical Indicators

Market Signals
Indicator
STTK
FRBA
Relative Strength Index (RSI) 36.78 46.99
Support Level $4.38 $17.04
Resistance Level $7.66 $19.21
Average True Range (ATR) 0.39 0.65
MACD -0.02 -0.14
Stochastic Oscillator 14.29 11.00

Price Performance

Historical Comparison
STTK
FRBA

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About FRBA First Bank

First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of business. Its services are Business Banking, Personal Banking, Digital Banking, and Lending.

Share on Social Networks: